Analyses of four cell lines and three primary tumors established the super-enhancer landscape of Ewing sarcoma, and revealed that super-enhancer-associated genes were exceptionally sensitive to inhibition of CDK7. The gene discussed is CDK7; the disease is Ewing sarcoma.